SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-286840
Filing Date
2022-11-16
Accepted
2022-11-16 16:53:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d417969d424b5.htm 424B5 502417
2 GRAPHIC g417969g01g01.jpg GRAPHIC 30052
3 GRAPHIC g417969g43g43.jpg GRAPHIC 51221
4 GRAPHIC g417969g69g69.jpg GRAPHIC 42808
  Complete submission text file 0001193125-22-286840.txt   663550
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266741 | Film No.: 221395861
SIC: 2836 Biological Products, (No Diagnostic Substances)